About Altos Labs
Altos Labs is a company based in San Carlos (United States) founded in 2018 by Benedetta Di Robilant was acquired by Altos Labs in May 2025. It operates as a HealthTech. Altos Labs has raised $150 thousand across 2 funding rounds from investors including HHS, Altos Labs and Y Combinator. The company has 9 employees as of December 31, 2022. Altos Labs offers products and services including Cellular Rejuvenation Programming. Altos Labs operates in a competitive market with competitors including Moderna, Horizon Therapeutics, Forge Biologics, argenx and Poseida Therapeutics, among others.
- Headquarter San Carlos, United States
- Employees 9 as on 31 Dec, 2022
- Founders Benedetta Di Robilant
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Altos Labs, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$150 K (USD)
in 2 rounds
-
Latest Funding Round
$335.65 K (USD), Grant
Sep 23, 2021
-
Investors
HHS
& 2 more
-
Employee Count
9
as on Dec 31, 2022
-
Acquired by
Altos Labs
(May 26, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Altos Labs
Altos Labs offers a comprehensive portfolio of products and services, including Cellular Rejuvenation Programming.
Cellular health is restored to reverse disease effects.
People of Altos Labs
Unlock access to complete
Unlock access to complete
Funding Insights of Altos Labs
Altos Labs has successfully raised a total of $150K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $335.65 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Altos Labs
Altos Labs has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Altos Labs and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Lab conducting research on cellular rejuvenation programming to restore cell health and resilience
|
Locked | Locked | Locked |
Investor details for Altos Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Altos Labs
Investment portfolio details for Altos Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Altos Labs
Detailed financials for Altos Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Altos Labs Comparisons
Peer comparison for Altos Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Altos Labs
Altos Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Horizon Therapeutics, Forge Biologics, argenx and Poseida Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Developer of drugs for treating rare and autoimmune diseases
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
Detailed competitors of Altos Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Altos Labs
Complete news archive for Altos Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altos Labs
Altos Labs was founded in 2018.
Altos Labs is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Altos Labs is a funded company, having raised a total of $150K across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Altos Labs is 9.
Altos Labs is dedicated to advancing cellular rejuvenation programming to reverse disease, injury, and disabilities. Research is conducted to understand deep biology and translate scientific breakthroughs into transformative medicine. The company operates in the biotechnology sector, fostering a collaborative culture across diverse disciplines to enhance human health outcomes.
Altos Labs's top competitors include Moderna, argenx and Forge Biologics.
Altos Labs offers Cellular Rejuvenation Programming.
Altos Labs has 3 investors. Key investors include HHS, Altos Labs, and Y Combinator.